ACST Top-line trial results for their triglyceride-reducing drug are going to be released towards the end of the month. A very similar trial had excellent results, this one should also.
That said, it's always very risky holding small bio's through binary events, and I'm not sure I will with this one. But there should be a run-up.
At $1.03 now, IMHO it's a fairly easy 10%-er from here in the next week or two. I have a large position.
All that is needed to make a happy life is within yourself, in your way of thinking. -Marcus Aurelius